1, 2, 3-triazole derivatives for use as stearoyl-CoA desaturase inhibitors

Details for Australian Patent Application No. 2008324172 (hide)

Owner GlaxoSmithKline LLC

Inventors Bouillot, Anne Marie Jeanne; Laroze, Alain; Trottet, Lionel

Agent Davies Collison Cave

Pub. Number AU-B-2008324172

PCT Pub. Number WO2009/060053

Priority 0722077.5 09.11.07 GB

Filing date 7 November 2008

Wipo publication date 14 May 2009

Acceptance publication date 15 March 2012

International Classifications

C07D 249/04 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/060053 Priority application(s): WO2009/060053

15 March 2012 Application Accepted

  Published as AU-B-2008324172

12 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324178-Amphiphilic water-soluble alkoxylated polyalkyleneimines having an inner polyethylene oxide block and an outer polypropylene oxide block

2008324152-Method for boriding of coatings using high speed electrolytic process